The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts
Candice Roufosse,Maarten Naesens,Mark Haas,Carmen Lefaucheur,Roslyn B Mannon,Marjan Afrouzian,Nada Alachkar,Olivier Aubert,Serena M Bagnasco,Ibrahim Batal,Chris O C Bellamy,Verena Broecker,Klemens Budde,Marian Clahsen-Van Groningen,Shana M Coley,Lynn D Cornell,Darshana Dadhania,Anthony J Demetris,Gunilla Einecke,Alton B Farris,Agnes B Fogo,John Friedewald,Ian W Gibson,Catherine Horsfield,Edmund Huang,Syed A Husain,Annette M Jackson,Jesper Kers,Željko Kikić,Amanda Klein,Nicolas Kozakowski,Helen Liapis,Massima Mangiola,Robert A Montgomery,Brian Nankinvell,Desley A H Neil,Peter Nickerson,Marion Rabant,Parmjeet Randhawa,Leonardo V Riella,Ivy Rosales,Virginie Royal,Ruth Sapir-Pichhadze,Pinaki Sarder,Minnie Sarwal,Carrie Schinstock,Mark Stegall,Kim Solez,Jeroen van der Laak,Chris Wiebe,Robert B Colvin,Alexandre Loupy,Michael Mengel
DOI: https://doi.org/10.1016/j.ajt.2023.10.031
Abstract:The XVIth Banff Meeting for Allograft Pathology was held in Banff, Alberta, Canada, from September 19 to 23, 2022, as a joint meeting with the Canadian Society of Transplantation. In addition to a key focus on the impact of microvascular inflammation and biopsy-based transcript analysis on the Banff Classification, further sessions were devoted to other aspects of kidney transplant pathology, in particular T cell-mediated rejection, activity and chronicity indices, digital pathology, xenotransplantation, clinical trials, and surrogate endpoints. Although the output of these sessions has not led to any changes in the classification, the key role of Banff Working Groups in phrasing unanswered questions, and coordinating and disseminating results of investigations addressing these unanswered questions was emphasized. This paper summarizes the key Banff Meeting 2022 sessions not covered in the Banff Kidney Meeting 2022 Report paper and also provides an update on other Banff Working Group activities relevant to kidney allografts.